Group One Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Group One Trading’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,597	Closed	-$43.6K	–	5156
2016 Q2	$46K	Sell	6,597 -12,965	-66%	-$91.4K	﹤0.01%	3358
2016 Q1	$129K	Buy	19,562 +11,013	+129%	+$81K	﹤0.01%	2653
2015 Q4	$88K	Buy	+8,549	New	+$99.1K	﹤0.01%	3067
2015 Q3	–	Sell	-203	Closed	-$2.24K	–	5454
2015 Q2	$2K	Buy	+203	New	+$1.53K	﹤0.01%	4707
2014 Q4	–	Sell	-19,408	Closed	-$114K	–	5537
2014 Q3	$114K	Buy	19,408 +1,760	+10%	+$10.7K	﹤0.01%	2869
2014 Q2	$121K	Buy	17,648 +3,081	+21%	+$20.6K	﹤0.01%	2810
2014 Q1	$105K	Buy	+14,567	New	+$101K	﹤0.01%	3028

Group One Trading's JNP Position: Q3 2016 in Review

Group One Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016, closing a stake of 6,597 shares — an estimated $43.6K sold.

Group One Trading first reported a position in JNP in Q1 2014 and held it in 7 quarters. The position peaked at $129K in Q1 2016. 46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.

Group One Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Group One Trading sold 6,597 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $43.6K.
Group One Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
Group One Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $129K in Q1 2016.
46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.